Zantac – MHRA drug alert issued as GlaxoSmithKline recalls all unexpired stock The MHRA has issued an alert to heathcare professionals, as GlaxoSmithKline is recalling all unexpired stock of four…
News Archive • Page 2 of 8 • Fortissa
Class 2 Medicines Recall: Co-amoxiclav 125 mg/31.25 mg/5 ml and 25 mg/62.5 mg/5 ml Powder for Oral Suspension (MDR 24-05/19) Product description Co-amoxiclav 125 mg/31.25 mg/5 ml Powder for Oral…
CLASS 4 MEDICINES DEFECT INFORMATION – Ativan 4mg/1ml Solution for injection Dear Healthcare Professional, Pfizer Limited Ativan 4mg/1ml Solution for injection PL 00057/1279 (Lorazepam) Batch Number Expiry Date Pack Size First…
Some valsartan containing products including certain batches supplied by Teva UK Limited and all unexpired batches supplied by Mylan are being recalled. Class 2 Medicines Recall: Teva UK Limited and…
UK pharmacies are assisting with the precautionary recall of Valsartan medication. The Medicines and Healthcare products Regulatory Agency (MHRA) are undertaking a pharmacy level recall of all affected batches of…
Valsartan from Mylan laboratories in India can no longer be used in EU medicines due to NDEA impurity Share Authorities in the EU are taking action after an impurity, N-nitrosodiethylamine…
European regulators pull Mylan’s manufacturing license for valsartan after impurities found European authorities have suspended Mylan’s (MYL -0.5%) manufacturing certificate for hypertension med valsartan after NDEA, a suspected carcinogen at…
Blood pressure and heart medication recalled from Pharmacies We are working with UK pharmacies to recall blood pressure and heart medication as a precaution Published 5 July 2018 Pharmacies in…
Class 1 Medicines Recall: Action Now – including out of hours Pharmacy Level Recall Pharmacies in the UK are being advised to recall all batches of valsartan containing medicines made…
Amazon’s purchase of an online pharmacy could “threaten” community pharmacies in the UK, an NHS deputy chief pharmacist has warned. The delivery giant announced that it had agreed to acquire…